PTCHF PureTech Health plc

USD 2.31 0.00 0
Icon

PureTech Health plc (PTCHF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.31

0.00 (0.00)%

USD 0.52B

0.05M

N/A

N/A

Icon

PTCHF

PureTech Health plc (USD)
COMMON STOCK | OTC
USD 2.31
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.52B

N/A

USD 2.31

PureTech Health plc (PTCHF) Stock Forecast

N/A

Based on the PureTech Health plc stock forecast from 0 analysts, the average analyst target price for PureTech Health plc is not available over the next 12 months. PureTech Health plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of PureTech Health plc is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, PureTech Health plc’s stock price was USD 2.31. PureTech Health plc’s stock price has changed by -5.71% over the past week, -6.29% over the past month and -14.03% over the last year.

No recent analyst target price found for PureTech Health plc
No recent average analyst rating found for PureTech Health plc

Company Overview PureTech Health plc

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pu...Read More

6 Tide Street, Boston, MA, United States, 02210

111

December

USD

USA

Adjusted Closing Price for PureTech Health plc (PTCHF)

Loading...

Unadjusted Closing Price for PureTech Health plc (PTCHF)

Loading...

Share Trading Volume for PureTech Health plc Shares

Loading...

Compare Performance of PureTech Health plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PTCHF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To PureTech Health plc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S 0.00 (0.00%) USD456.53B 41.43 4.67

ETFs Containing PTCHF

Symbol Name PTCHF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About PureTech Health plc (PTCHF) Stock

Stock Target Advisor's fundamental analysis for PureTech Health plc's stock is Slightly Bearish.

Unfortunately we do not have enough data on PTCHF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PTCHF's stock to indicate what its average analyst target is.

PTCHF stock's Price/Earning ratio is 236.00. Our analysis grades PTCHF stock's Price / Earning ratio at F. This means that PTCHF stock's Price/Earning ratio is above 95% of the stocks in the Biotechnology sector in the OTC exchange. Based on this PTCHF may be a overvalued for its sector.

The last closing price of PTCHF's stock was USD 2.31.

The most recent market capitalization for PTCHF is USD 0.52B.

Unfortunately we do not have enough analyst data on PTCHF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains PureTech Health plc's stock.

As per our most recent records PureTech Health plc has 111 Employees.

PureTech Health plc's registered address is 6 Tide Street, Boston, MA, United States, 02210. You can get more information about it from PureTech Health plc's website at https://www.puretechhealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...